Read More Retail Industry News Dr. Martens (LSE: DOCS) shares plunge 12% as FY26 Q3 trading shows margin discipline at the cost of top-line softness Dr. Martens stock plunged 12% after Q3 FY26 results. Find out why the flat revenue outlook and DTC weakness are testing investor confidence. bySrinathJanuary 27, 2026